Agree. The answer lies in the treatment(s), not the vaccine.
If given late at hospitalization, Leronlimab looks like a top choice among many other mid-late stage drugs like Remd and Tocil, or at least has a good enough or better profile to compete very well.
That said, my choice at the hospitalization stage would be convalescent plasma first, if available.
This will all end once a bona fide, non politicized treatment at home BEFORE needing hospitalization is shared worldwide. Right now, it "appears" that HCQ+Azith+Zinc is the front runner if given early and prior to hospitalization.
People will unfortunately still die from this regardless of a treatment or vaccine. Just like every other virus in the world.
Market Data 
Markets 
AI
